Human Genetic Variation Alters Anthrax Toxin Sensitivity
Martchenko, Candille et al., PNAS
Researchers at Stanford University School of Medicine show that genetic variation affecting capillary morphogenesis gene 2, or CMG2, dramatically alters toxin sensitivity in humans. In its analysis, the team reports on "a CMG2 single-nucleotide polymorphism occurring frequently in African and European populations [that they found] independently altered toxin uptake." The group goes on to suggest "testing of genomically characterized human cell populations may offer a broadly useful strategy for elucidating effects of genetic variation on infectious disease susceptibility."
Korean CDC and Macrogen Partner with Roche NimbleGen for CNV-Association Study
According to officials from both Macrogen and Roche, the study is an example of what they see as a growing desire from customers involved in SNP association studies to also look at CNVs across the same populations.
New to GenomeWeb? Register quickly here.